Skip to main content
PMC home page
Gut logoLink to Gut
. 2005 Jun;54(Suppl 5):v1–v16. doi: 10.1136/gut.2004.057059

Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas

S Pancreatic
PMCID: PMC1867803  PMID: 15888770

Full Text

The Full Text of this article is available as a PDF (172.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen-Mersh T. G., Earlam R. J. Pancreatic cancer in England and Wales: surgeons look at epidemiology. Ann R Coll Surg Engl. 1986 May;68(3):154–158. [PMC free article] [PubMed] [Google Scholar]
  2. Andersen J. R., Sørensen S. M., Kruse A., Rokkjaer M., Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989 Aug;30(8):1132–1135. doi: 10.1136/gut.30.8.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. André T., Balosso J., Louvet C., Hannoun L., Houry S., Huguier M., Colonna M., Lotz J. P., De Gramont A., Bellaïche A. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):903–911. doi: 10.1016/s0360-3016(99)00478-2. [DOI] [PubMed] [Google Scholar]
  4. Andrén-Sandberg A., Ihse I. Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg. 1983 Nov;198(5):605–610. doi: 10.1097/00000658-198311000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Andrén-Sandberg Å, Zoucas E, Lillo-Gil R, Gyllstedt E, Ihse I., I Thoracoscopic Splanchnicectomy for Chronic, Severe Pancreatic Pain. Semin Laparosc Surg. 1996 Mar;3(1):29–33. doi: 10.1053/SLAS00300029. [DOI] [PubMed] [Google Scholar]
  6. Bakkevold K. E., Arnesjø B., Dahl O., Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993;29A(5):698–703. doi: 10.1016/s0959-8049(05)80349-1. [DOI] [PubMed] [Google Scholar]
  7. Bakkevold K. E., Pettersen A., Arnesjø B., Espehaug B. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater. Br J Surg. 1990 Jul;77(7):725–730. doi: 10.1002/bjs.1800770704. [DOI] [PubMed] [Google Scholar]
  8. Bansal P., Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology. 1995 Jul;109(1):247–251. doi: 10.1016/0016-5085(95)90291-0. [DOI] [PubMed] [Google Scholar]
  9. Barber M. D., Ross J. A., Voss A. C., Tisdale M. J., Fearon K. C. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999 Sep;81(1):80–86. doi: 10.1038/sj.bjc.6690654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Baumel H., Huguier M., Manderscheid J. C., Fabre J. M., Houry S., Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg. 1994 Jan;81(1):102–107. doi: 10.1002/bjs.1800810138. [DOI] [PubMed] [Google Scholar]
  11. Bergman W., Watson P., de Jong J., Lynch H. T., Fusaro R. M. Systemic cancer and the FAMMM syndrome. Br J Cancer. 1990 Jun;61(6):932–936. doi: 10.1038/bjc.1990.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Birkmeyer John D., Siewers Andrea E., Finlayson Emily V. A., Stukel Therese A., Lucas F. Lee, Batista Ida, Welch H. Gilbert, Wennberg David E. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002 Apr 11;346(15):1128–1137. doi: 10.1056/NEJMsa012337. [DOI] [PubMed] [Google Scholar]
  13. Blamey S. L., Fearon K. C., Gilmour W. H., Osborne D. H., Carter D. C. Prediction of risk in biliary surgery. Br J Surg. 1983 Sep;70(9):535–538. doi: 10.1002/bjs.1800700910. [DOI] [PubMed] [Google Scholar]
  14. Bodner E. Leistungen der Tumorchirurgie bei Tumoren der Bauchspeicheldrüse. Langenbecks Arch Chir. 1988;Suppl 2:133–138. [PubMed] [Google Scholar]
  15. Boz G., De Paoli A., Innocente R., Rossi C., Tosolini G., Pederzoli P., Talamini R., Trovò M. G. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):736–740. doi: 10.1016/s0360-3016(01)01708-4. [DOI] [PubMed] [Google Scholar]
  16. Braasch J. W., Deziel D. J., Rossi R. L., Watkins E., Jr, Winter P. F. Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg. 1986 Oct;204(4):411–418. doi: 10.1097/00000658-198610000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bramhall S. R., Allum W. H., Jones A. G., Allwood A., Cummins C., Neoptolemos J. P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995 Jan;82(1):111–115. doi: 10.1002/bjs.1800820137. [DOI] [PubMed] [Google Scholar]
  18. Bramhall S. R., Rosemurgy A., Brown P. D., Bowry C., Buckels J. A., Marimastat Pancreatic Cancer Study Group Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. J Clin Oncol. 2001 Aug 1;19(15):3447–3455. doi: 10.1200/JCO.2001.19.15.3447. [DOI] [PubMed] [Google Scholar]
  19. Brandt K. R., Charboneau J. W., Stephens D. H., Welch T. J., Goellner J. R. CT- and US-guided biopsy of the pancreas. Radiology. 1993 Apr;187(1):99–104. doi: 10.1148/radiology.187.1.8451443. [DOI] [PubMed] [Google Scholar]
  20. Breslin T. M., Hess K. R., Harbison D. B., Jean M. E., Cleary K. R., Dackiw A. P., Wolff R. A., Abbruzzese J. L., Janjan N. A., Crane C. H. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol. 2001 Mar;8(2):123–132. doi: 10.1007/s10434-001-0123-4. [DOI] [PubMed] [Google Scholar]
  21. Bret P. M., Reinhold C. Magnetic resonance cholangiopancreatography. Endoscopy. 1997 Aug;29(6):472–486. doi: 10.1055/s-2007-1004252. [DOI] [PubMed] [Google Scholar]
  22. Bruno M. J., Haverkort E. B., Tijssen G. P., Tytgat G. N., van Leeuwen D. J. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut. 1998 Jan;42(1):92–96. doi: 10.1136/gut.42.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Burris H. A., 3rd, Moore M. J., Andersen J., Green M. R., Rothenberg M. L., Modiano M. R., Cripps M. C., Portenoy R. K., Storniolo A. M., Tarassoff P. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997 Jun;15(6):2403–2413. doi: 10.1200/JCO.1997.15.6.2403. [DOI] [PubMed] [Google Scholar]
  24. Cameron J. L., Crist D. W., Sitzmann J. V., Hruban R. H., Boitnott J. K., Seidler A. J., Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991 Jan;161(1):120–125. doi: 10.1016/0002-9610(91)90371-j. [DOI] [PubMed] [Google Scholar]
  25. Cameron J. L., Pitt H. A., Yeo C. J., Lillemoe K. D., Kaufman H. S., Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993 May;217(5):430–438. doi: 10.1097/00000658-199305010-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Chang K. J., Nguyen P., Erickson R. A., Durbin T. E., Katz K. D. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc. 1997 May;45(5):387–393. doi: 10.1016/s0016-5107(97)70149-4. [DOI] [PubMed] [Google Scholar]
  27. Choi B. I., Chung M. J., Han J. K., Han M. C., Yoon Y. B. Detection of pancreatic adenocarcinoma: relative value of arterial and late phases of spiral CT. Abdom Imaging. 1997 Mar-Apr;22(2):199–203. doi: 10.1007/s002619900172. [DOI] [PubMed] [Google Scholar]
  28. Chong M., Freeny P. C., Schmiedl U. P. Pancreatic arterial anatomy: depiction with dual-phase helical CT. Radiology. 1998 Aug;208(2):537–542. doi: 10.1148/radiology.208.2.9680589. [DOI] [PubMed] [Google Scholar]
  29. Coley S. C., Strickland N. H., Walker J. D., Williamson R. C. Spiral CT and the pre-operative assessment of pancreatic adenocarcinoma. Clin Radiol. 1997 Jan;52(1):24–30. doi: 10.1016/s0009-9260(97)80301-7. [DOI] [PubMed] [Google Scholar]
  30. Compagno J., Oertel J. E. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol. 1978 Jun;69(6):573–580. doi: 10.1093/ajcp/69.6.573. [DOI] [PubMed] [Google Scholar]
  31. Cotton P. B. ERCP. Gut. 1977 Apr;18(4):316–341. doi: 10.1136/gut.18.4.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Cotton P. B., Lees W. R., Vallon A. G., Cottone M., Croker J. R., Chapman M. Gray-scale ultrasonography and endoscopic pancreatography in pancreatic diagnosis. Radiology. 1980 Feb;134(2):453–459. doi: 10.1148/radiology.134.2.7352230. [DOI] [PubMed] [Google Scholar]
  33. Coughlin S. S., Calle E. E., Patel A. V., Thun M. J. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control. 2000 Dec;11(10):915–923. doi: 10.1023/a:1026580131793. [DOI] [PubMed] [Google Scholar]
  34. Cubilla A. L., Fitzgerald P. J. Morphological patterns of primary nonendocrine human pancreas carcinoma. Cancer Res. 1975 Aug;35(8):2234–2248. [PubMed] [Google Scholar]
  35. Cullinan S., Moertel C. G., Wieand H. S., Schutt A. J., Krook J. E., Foley J. F., Norris B. D., Kardinal C. G., Tschetter L. K., Barlow J. F. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer. 1990 May 15;65(10):2207–2212. doi: 10.1002/1097-0142(19900515)65:10<2207::aid-cncr2820651007>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  36. Davids P. H., Groen A. K., Rauws E. A., Tytgat G. N., Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992 Dec 19;340(8834-8835):1488–1492. doi: 10.1016/0140-6736(92)92752-2. [DOI] [PubMed] [Google Scholar]
  37. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994 Oct 8;309(6959):901–911. doi: 10.1136/bmj.309.6959.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Dowsett J. F., Vaira D., Hatfield A. R., Cairns S. R., Polydorou A., Frost R., Croker J., Cotton P. B., Russell R. C., Mason R. R. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology. 1989 Apr;96(4):1180–1186. doi: 10.1016/0016-5085(89)91639-9. [DOI] [PubMed] [Google Scholar]
  39. Dupuy D. E., Costello P., Ecker C. P. Spiral CT of the pancreas. Radiology. 1992 Jun;183(3):815–818. doi: 10.1148/radiology.183.3.1584940. [DOI] [PubMed] [Google Scholar]
  40. Edis A. J., Kiernan P. D., Taylor W. F. Attempted curative resection of ductal carcinoma of the pancreas: review of Mayo Clinic experience, 1951-1975. Mayo Clin Proc. 1980 Sep;55(9):531–536. [PubMed] [Google Scholar]
  41. Evans J. D., Stark A., Johnson C. D., Daniel F., Carmichael J., Buckels J., Imrie C. W., Brown P., Neoptolemos J. P. A phase II trial of marimastat in advanced pancreatic cancer. Br J Cancer. 2001 Dec 14;85(12):1865–1870. doi: 10.1054/bjoc.2001.2168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Falconer J. S., Fearon K. C., Ross J. A., Elton R., Wigmore S. J., Garden O. J., Carter D. C. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer. 1995 Apr 15;75(8):2077–2082. doi: 10.1002/1097-0142(19950415)75:8<2077::aid-cncr2820750808>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  43. Falk R. T., Pickle L. W., Fontham E. T., Correa P., Fraumeni J. F., Jr Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol. 1988 Aug;128(2):324–336. doi: 10.1093/oxfordjournals.aje.a114972. [DOI] [PubMed] [Google Scholar]
  44. Fernandez E., La Vecchia C., Porta M., Negri E., Lucchini F., Levi F. Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer. 1994 Jun 15;57(6):786–792. doi: 10.1002/ijc.2910570605. [DOI] [PubMed] [Google Scholar]
  45. Ferrucci J. T., Wittenberg J., Margolies M. N., Carey R. W. Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology. 1979 Feb;130(2):345–346. doi: 10.1148/130.2.345. [DOI] [PubMed] [Google Scholar]
  46. Fink A. S., DeSouza L. R., Mayer E. A., Hawkins R., Longmire W. P., Jr Long-term evaluation of pylorus preservation during pancreaticoduodenectomy. World J Surg. 1988 Oct;12(5):663–670. doi: 10.1007/BF01655880. [DOI] [PubMed] [Google Scholar]
  47. Fortner J. G., Kim D. K., Cubilla A., Turnbull A., Pahnke L. D., Shils M. E. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977 Jul;186(1):42–50. doi: 10.1097/00000658-197707000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Fortner J. G. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg. 1984 Apr;199(4):418–425. doi: 10.1097/00000658-198404000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Fras I., Litin E. M., Pearson J. S. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry. 1967 Jun;123(12):1553–1562. doi: 10.1176/ajp.123.12.1553. [DOI] [PubMed] [Google Scholar]
  50. Freeny P. C., Marks W. M., Ryan J. A., Traverso L. W. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology. 1988 Jan;166(1 Pt 1):125–133. doi: 10.1148/radiology.166.1.2827228. [DOI] [PubMed] [Google Scholar]
  51. Freeny P. C., Traverso L. W., Ryan J. A. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg. 1993 May;165(5):600–606. doi: 10.1016/s0002-9610(05)80443-x. [DOI] [PubMed] [Google Scholar]
  52. Fuhrman G. M., Charnsangavej C., Abbruzzese J. L., Cleary K. R., Martin R. G., Fenoglio C. J., Evans D. B. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg. 1994 Jan;167(1):104–113. doi: 10.1016/0002-9610(94)90060-4. [DOI] [PubMed] [Google Scholar]
  53. Funovics J. M., Karner J., Pratschner T., Fritsch A. Current trends in the management of carcinoma of the pancreatic head. Hepatogastroenterology. 1989 Dec;36(6):450–455. [PubMed] [Google Scholar]
  54. Gambill E. E. Pancreatitis associated with pancreatic carcinoma: a study of 26 cases. Mayo Clin Proc. 1971 Mar;46(3):174–177. [PubMed] [Google Scholar]
  55. Ghadirian P., Simard A., Baillargeon J. Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer. 1991 May 15;67(10):2664–2670. doi: 10.1002/1097-0142(19910515)67:10<2664::aid-cncr2820671043>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  56. Giardiello F. M., Brensinger J. D., Tersmette A. C., Goodman S. N., Petersen G. M., Booker S. V., Cruz-Correa M., Offerhaus J. A. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000 Dec;119(6):1447–1453. doi: 10.1053/gast.2000.20228. [DOI] [PubMed] [Google Scholar]
  57. Glasgow R. E., Mulvihill S. J. Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med. 1996 Nov;165(5):294–300. [PMC free article] [PubMed] [Google Scholar]
  58. Glimelius B., Hoffman K., Sjödén P. O., Jacobsson G., Sellström H., Enander L. K., Linné T., Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol. 1996 Aug;7(6):593–600. doi: 10.1093/oxfordjournals.annonc.a010676. [DOI] [PubMed] [Google Scholar]
  59. Gordis L., Gold E. B. Epidemiology of pancreatic cancer. World J Surg. 1984 Dec;8(6):808–821. doi: 10.1007/BF01656020. [DOI] [PubMed] [Google Scholar]
  60. Grace P. A., Pitt H. A., Longmire W. P. Pancreatoduodenectomy with pylorus preservation for adenocarcinoma of the head of the pancreas. Br J Surg. 1986 Aug;73(8):647–650. doi: 10.1002/bjs.1800730824. [DOI] [PubMed] [Google Scholar]
  61. Griffanti-Bartoli F., Arnone G. B., Ceppa P., Ravera G., Carrabetta S., Civalleri D. Malignant tumors in the head of the pancreas and the periampullary region. Diagnostic and prognostic aspects. Anticancer Res. 1994 Mar-Apr;14(2B):657–666. [PubMed] [Google Scholar]
  62. Groves C. J., Saunders B. P., Spigelman A. D., Phillips R. K. S. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut. 2002 May;50(5):636–641. doi: 10.1136/gut.50.5.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Gullo L., Pezzilli R., Morselli-Labate A. M., Italian Pancreatic Cancer Study Group Diabetes and the risk of pancreatic cancer. N Engl J Med. 1994 Jul 14;331(2):81–84. doi: 10.1056/NEJM199407143310203. [DOI] [PubMed] [Google Scholar]
  64. Hahn Stephan A., Greenhalf Bill, Ellis Ian, Sina-Frey Mercedes, Rieder Harald, Korte Birgit, Gerdes Berthold, Kress Ralf, Ziegler Andreas, Raeburn John A. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 2003 Feb 5;95(3):214–221. doi: 10.1093/jnci/95.3.214. [DOI] [PubMed] [Google Scholar]
  65. Hatfield A. R., Tobias R., Terblanche J., Girdwood A. H., Fataar S., Harries-Jones R., Kernoff L., Marks I. N. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 1982 Oct 23;2(8304):896–899. doi: 10.1016/s0140-6736(82)90866-2. [DOI] [PubMed] [Google Scholar]
  66. Haycox A., Lombard M., Neoptolemos J., Walley T. Review article: current treatment and optimal patient management in pancreatic cancer. Aliment Pharmacol Ther. 1998 Oct;12(10):949–964. doi: 10.1046/j.1365-2036.1998.00390.x. [DOI] [PubMed] [Google Scholar]
  67. Herter F. P., Cooperman A. M., Ahlborn T. N., Antinori C. Surgical experience with pancreatic and periampullary cancer. Ann Surg. 1982 Mar;195(3):274–281. doi: 10.1097/00000658-198203000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Hiraoka T. Extended radical resection of cancer of the pancreas with intraoperative radiotherapy. Baillieres Clin Gastroenterol. 1990 Dec;4(4):985–993. doi: 10.1016/0950-3528(90)90031-b. [DOI] [PubMed] [Google Scholar]
  69. Hockley J. M., Dunlop R., Davies R. J. Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team. Br Med J (Clin Res Ed) 1988 Jun 18;296(6638):1715–1717. doi: 10.1136/bmj.296.6638.1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Holland J. C., Korzun A. H., Tross S., Silberfarb P., Perry M., Comis R., Oster M. Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry. 1986 Aug;143(8):982–986. doi: 10.1176/ajp.143.8.982. [DOI] [PubMed] [Google Scholar]
  71. Hollett M. D., Jeffrey R. B., Jr, Nino-Murcia M., Jorgensen M. J., Harris D. P. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol. 1995 Apr;164(4):879–884. doi: 10.2214/ajr.164.4.7726040. [DOI] [PubMed] [Google Scholar]
  72. Howard T. J., Chin A. C., Streib E. W., Kopecky K. K., Wiebke E. A. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg. 1997 Sep;174(3):237–241. doi: 10.1016/s0002-9610(97)00132-3. [DOI] [PubMed] [Google Scholar]
  73. Ichikawa T., Haradome H., Hachiya J., Nitatori T., Ohtomo K., Kinoshita T., Araki T. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology. 1997 Mar;202(3):655–662. doi: 10.1148/radiology.202.3.9051012. [DOI] [PubMed] [Google Scholar]
  74. Ihse I., Lilja P., Arnesjö B., Bengmark S. Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg. 1977 Dec;186(6):675–680. doi: 10.1097/00000658-197712000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Ishikawa O., Ohhigashi H., Teshima T., Chatani M., Inoue T., Tanaka S., Kitamura T., Wada A., Sasaki Y., Imaoka S. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. J Surg Oncol. 1989 Mar;40(3):143–151. doi: 10.1002/jso.2930400303. [DOI] [PubMed] [Google Scholar]
  76. Jagelman D. G., DeCosse J. J., Bussey H. J. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet. 1988 May 21;1(8595):1149–1151. doi: 10.1016/s0140-6736(88)91962-9. [DOI] [PubMed] [Google Scholar]
  77. Jennings P. E., Donald J. J., Coral A., Rode J., Lees W. R. Ultrasound-guided core biopsy. Lancet. 1989 Jun 17;1(8651):1369–1371. doi: 10.1016/s0140-6736(89)92813-4. [DOI] [PubMed] [Google Scholar]
  78. Johnson C. D., Schwall G., Flechtenmacher J., Trede M. Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg. 1993 Sep;80(9):1177–1179. doi: 10.1002/bjs.1800800937. [DOI] [PubMed] [Google Scholar]
  79. Karlson B. M., Ekbom A., Lindgren P. G., Källskog V., Rastad J. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology. 1999 Oct;213(1):107–111. doi: 10.1148/radiology.213.1.r99oc25107. [DOI] [PubMed] [Google Scholar]
  80. Klaassen D. J., MacIntyre J. M., Catton G. E., Engstrom P. F., Moertel C. G. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol. 1985 Mar;3(3):373–378. doi: 10.1200/JCO.1985.3.3.373. [DOI] [PubMed] [Google Scholar]
  81. Klinkenbijl J. H., Jeekel J., Sahmoud T., van Pel R., Couvreur M. L., Veenhof C. H., Arnaud J. P., Gonzalez D. G., de Wit L. T., Hennipman A. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999 Dec;230(6):776–784. doi: 10.1097/00000658-199912000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Klinkenbijl J. H., Jeekel J., Schmitz P. I., Rombout P. A., Nix G. A., Bruining H. A., van Blankenstein M. Carcinoma of the pancreas and periampullary region: palliation versus cure. Br J Surg. 1993 Dec;80(12):1575–1578. doi: 10.1002/bjs.1800801227. [DOI] [PubMed] [Google Scholar]
  83. Ko Andrew H., Tempero Margaret A. Current and future strategies for combined-modality therapy in pancreatic cancer. Curr Oncol Rep. 2002 May;4(3):202–212. doi: 10.1007/s11912-002-0017-z. [DOI] [PubMed] [Google Scholar]
  84. Kurzawinski T., Deery A., Davidson B. R. Diagnostic value of cytology for biliary stricture. Br J Surg. 1993 Apr;80(4):414–421. doi: 10.1002/bjs.1800800404. [DOI] [PubMed] [Google Scholar]
  85. Lai E. C., Chu K. M., Lo C. Y., Mok F. P., Fan S. T., Lo C. M., Wong J. Surgery for malignant obstructive jaundice: analysis of mortality. Surgery. 1992 Nov;112(5):891–896. [PubMed] [Google Scholar]
  86. Lai E. C., Mok F. P., Fan S. T., Lo C. M., Chu K. M., Liu C. L., Wong J. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg. 1994 Aug;81(8):1195–1198. doi: 10.1002/bjs.1800810839. [DOI] [PubMed] [Google Scholar]
  87. Launois B., Franci J., Bardaxoglou E., Ramee M. P., Paul J. L., Malledant Y., Campion J. P. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg. 1993 Jan-Feb;17(1):122–127. doi: 10.1007/BF01655724. [DOI] [PubMed] [Google Scholar]
  88. Leach S. D., Lee J. E., Charnsangavej C., Cleary K. R., Lowy A. M., Fenoglio C. J., Pisters P. W., Evans D. B. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg. 1998 May;85(5):611–617. doi: 10.1046/j.1365-2168.1998.00641.x. [DOI] [PubMed] [Google Scholar]
  89. Leach S. D., Rose J. A., Lowy A. M., Lee J. E., Charnsangavej C., Abbruzzese J. L., Katz R. L., Evans D. B. Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery. 1995 Sep;118(3):472–478. doi: 10.1016/s0039-6060(05)80361-7. [DOI] [PubMed] [Google Scholar]
  90. Lees W. R. Pancreatic ultrasonography. Clin Gastroenterol. 1984 Sep;13(3):763–789. [PubMed] [Google Scholar]
  91. Legmann P., Vignaux O., Dousset B., Baraza A. J., Palazzo L., Dumontier I., Coste J., Louvel A., Roseau G., Couturier D. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998 May;170(5):1315–1322. doi: 10.2214/ajr.170.5.9574609. [DOI] [PubMed] [Google Scholar]
  92. Leung J. W., Ling T. K., Kung J. L., Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointest Endosc. 1988 Jan-Feb;34(1):19–22. doi: 10.1016/s0016-5107(88)71223-7. [DOI] [PubMed] [Google Scholar]
  93. Lichtenstein D. R., Carr-Locke D. L. Endoscopic palliation for unresectable pancreatic carcinoma. Surg Clin North Am. 1995 Oct;75(5):969–988. doi: 10.1016/s0039-6109(16)46740-x. [DOI] [PubMed] [Google Scholar]
  94. Lieberman M. D., Kilburn H., Lindsey M., Brennan M. F. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995 Nov;222(5):638–645. doi: 10.1097/00000658-199511000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Lillemoe K. D., Cameron J. L., Hardacre J. M., Sohn T. A., Sauter P. K., Coleman J., Pitt H. A., Yeo C. J. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999 Sep;230(3):322–330. doi: 10.1097/00000658-199909000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Lillemoe K. D., Cameron J. L., Kaufman H. S., Yeo C. J., Pitt H. A., Sauter P. K. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg. 1993 May;217(5):447–457. doi: 10.1097/00000658-199305010-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Livingston E. H., Welton M. L., Reber H. A. Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol. 1991 Summer;9:153–157. doi: 10.1007/BF02925591. [DOI] [PubMed] [Google Scholar]
  98. Lowenfels A. B., Maisonneuve P., Cavallini G., Ammann R. W., Lankisch P. G., Andersen J. R., Dimagno E. P., Andrén-Sandberg A., Domellöf L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993 May 20;328(20):1433–1437. doi: 10.1056/NEJM199305203282001. [DOI] [PubMed] [Google Scholar]
  99. Lowenfels A. B., Maisonneuve P., DiMagno E. P., Elitsur Y., Gates L. K., Jr, Perrault J., Whitcomb D. C. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. 1997 Mar 19;89(6):442–446. doi: 10.1093/jnci/89.6.442. [DOI] [PubMed] [Google Scholar]
  100. Lynch H. T., Fusaro R. M. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas. 1991 Mar;6(2):127–131. doi: 10.1097/00006676-199103000-00001. [DOI] [PubMed] [Google Scholar]
  101. Lynch H. T., Smyrk T. C., Watson P., Lanspa S. J., Lynch J. F., Lynch P. M., Cavalieri R. J., Boland C. R. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993 May;104(5):1535–1549. doi: 10.1016/0016-5085(93)90368-m. [DOI] [PubMed] [Google Scholar]
  102. Mack T. M., Yu M. C., Hanisch R., Henderson B. E. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst. 1986 Jan;76(1):49–60. [PubMed] [Google Scholar]
  103. Maisey Nick, Chau Ian, Cunningham David, Norman Andrew, Seymour Matt, Hickish Tamas, Iveson Tim, O'Brien Mary, Tebbutt Niall, Harrington Angela. Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer. J Clin Oncol. 2002 Jul 15;20(14):3130–3136. doi: 10.1200/JCO.2002.09.029. [DOI] [PubMed] [Google Scholar]
  104. Mallinson C. N., Rake M. O., Cocking J. B., Fox C. A., Cwynarski M. T., Diffey B. L., Jackson G. A., Hanley J., Wass V. J. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial. Br Med J. 1980 Dec 13;281(6255):1589–1591. doi: 10.1136/bmj.281.6255.1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Marcus S. G., Dobryansky M., Shamamian P., Cohen H., Gouge T. H., Pachter H. L., Eng K. Endoscopic biliary drainage before pancreaticoduodenectomy for periampullary malignancies. J Clin Gastroenterol. 1998 Mar;26(2):125–129. doi: 10.1097/00004836-199803000-00008. [DOI] [PubMed] [Google Scholar]
  106. Martignoni M. E., Wagner M., Krähenbühl L., Redaelli C. A., Friess H., Büchler M. W. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg. 2001 Jan;181(1):52–87. doi: 10.1016/s0002-9610(00)00528-6. [DOI] [PubMed] [Google Scholar]
  107. McCarthy M. J., Evans J., Sagar G., Neoptolemos J. P. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg. 1998 Mar;85(3):320–325. doi: 10.1046/j.1365-2168.1998.00584.x. [DOI] [PubMed] [Google Scholar]
  108. McLeod R. S., Taylor B. R., O'Connor B. I., Greenberg G. R., Jeejeebhoy K. N., Royall D., Langer B. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg. 1995 Jan;169(1):179–185. doi: 10.1016/s0002-9610(99)80129-9. [DOI] [PubMed] [Google Scholar]
  109. McPherson G. A., Benjamin I. S., Hodgson H. J., Bowley N. B., Allison D. J., Blumgart L. H. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 1984 May;71(5):371–375. doi: 10.1002/bjs.1800710522. [DOI] [PubMed] [Google Scholar]
  110. Megibow A. J., Zhou X. H., Rotterdam H., Francis I. R., Zerhouni E. A., Balfe D. M., Weinreb J. C., Aisen A., Kuhlman J., Heiken J. P. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group. Radiology. 1995 May;195(2):327–332. doi: 10.1148/radiology.195.2.7724748. [DOI] [PubMed] [Google Scholar]
  111. Merchant N. B., Conlon K. C., Saigo P., Dougherty E., Brennan M. F. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg. 1999 Apr;188(4):421–426. doi: 10.1016/s1072-7515(98)00327-5. [DOI] [PubMed] [Google Scholar]
  112. Mertz H. R., Sechopoulos P., Delbeke D., Leach S. D. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc. 2000 Sep;52(3):367–371. doi: 10.1067/mge.2000.107727. [DOI] [PubMed] [Google Scholar]
  113. Midwinter M. J., Beveridge C. J., Wilsdon J. B., Bennett M. K., Baudouin C. J., Charnley R. M. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg. 1999 Feb;86(2):189–193. doi: 10.1046/j.1365-2168.1999.01042.x. [DOI] [PubMed] [Google Scholar]
  114. Moertel C. G., Childs D. S., Jr, Reitemeier R. J., Colby M. Y., Jr, Holbrook M. A. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 1969 Oct 25;2(7626):865–867. doi: 10.1016/s0140-6736(69)92326-5. [DOI] [PubMed] [Google Scholar]
  115. Moossa A. R., Levin B. The diagnosis of "early" pancreatic cancer: the University of Chicago experience. Cancer. 1981 Mar 15;47(6 Suppl):1688–1697. doi: 10.1002/1097-0142(19810315)47:6+<1688::aid-cncr2820471438>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  116. Morgan R. G., Wormsley K. G. Progress report. Cancer of the pancreas. Gut. 1977 Jul;18(7):580–596. doi: 10.1136/gut.18.7.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Murphy Kathleen M., Brune Kieran A., Griffin Constance, Sollenberger Jennifer E., Petersen Gloria M., Bansal Ravi, Hruban Ralph H., Kern Scott E. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002 Jul 1;62(13):3789–3793. [PubMed] [Google Scholar]
  118. Murugiah M., Paterson-Brown S., Windsor J. A., Miles W. F., Garden O. J. Early experience of laparoscopic ultrasonography in the management of pancreatic carcinoma. Surg Endosc. 1993 May-Jun;7(3):177–181. doi: 10.1007/BF00594102. [DOI] [PubMed] [Google Scholar]
  119. Murugiah M., Windsor J. A., Redhead D. N., O'Neill J. S., Suc B., Garden O. J., Carter D. C. The role of selective visceral angiography in the management of pancreatic and periampullary cancer. World J Surg. 1993 Nov-Dec;17(6):796–800. doi: 10.1007/BF01659101. [DOI] [PubMed] [Google Scholar]
  120. Müller M. F., Meyenberger C., Bertschinger P., Schaer R., Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994 Mar;190(3):745–751. doi: 10.1148/radiology.190.3.8115622. [DOI] [PubMed] [Google Scholar]
  121. Nakao A., Harada A., Nonami T., Kaneko T., Murakami H., Inoue S., Takeuchi Y., Takagi H. Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg. 1995 Mar;82(3):399–402. doi: 10.1002/bjs.1800820340. [DOI] [PubMed] [Google Scholar]
  122. Neoptolemos J. P., Dunn J. A., Stocken D. D., Almond J., Link K., Beger H., Bassi C., Falconi M., Pederzoli P., Dervenis C. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001 Nov 10;358(9293):1576–1585. doi: 10.1016/s0140-6736(01)06651-x. [DOI] [PubMed] [Google Scholar]
  123. Neoptolemos J. P., Russell R. C., Bramhall S., Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg. 1997 Oct;84(10):1370–1376. [PubMed] [Google Scholar]
  124. Neoptolemos J. P., Stocken D. D., Dunn J. A., Almond J., Beger H. G., Pederzoli P., Bassi C., Dervenis C., Fernandez-Cruz L., Lacaine F. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001 Dec;234(6):758–768. doi: 10.1097/00000658-200112000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Novick S. L., Fishman E. K. Three-dimensional CT angiography of pancreatic carcinoma: role in staging extent of disease. AJR Am J Roentgenol. 1998 Jan;170(1):139–143. doi: 10.2214/ajr.170.1.9423619. [DOI] [PubMed] [Google Scholar]
  126. O'Brien S., Hatfield A. R., Craig P. I., Williams S. P. A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut. 1995 Apr;36(4):618–621. doi: 10.1136/gut.36.4.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Offerhaus G. J., Giardiello F. M., Krush A. J., Booker S. V., Tersmette A. C., Kelley N. C., Hamilton S. R. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992 Jun;102(6):1980–1982. doi: 10.1016/0016-5085(92)90322-p. [DOI] [PubMed] [Google Scholar]
  128. Palazzo L., Roseau G., Gayet B., Vilgrain V., Belghiti J., Fékéte F., Paolaggi J. A. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy. 1993 Feb;25(2):143–150. doi: 10.1055/s-2007-1010273. [DOI] [PubMed] [Google Scholar]
  129. Palmer K. R., Kerr M., Knowles G., Cull A., Carter D. C., Leonard R. C. Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg. 1994 Jun;81(6):882–885. doi: 10.1002/bjs.1800810629. [DOI] [PubMed] [Google Scholar]
  130. Parkin D. M., Bray F. I., Devesa S. S. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001 Oct;37 (Suppl 8):S4–66. doi: 10.1016/s0959-8049(01)00267-2. [DOI] [PubMed] [Google Scholar]
  131. Pedrazzoli S., DiCarlo V., Dionigi R., Mosca F., Pederzoli P., Pasquali C., Klöppel G., Dhaene K., Michelassi F. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998 Oct;228(4):508–517. doi: 10.1097/00000658-199810000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Perez M. M., Newcomer A. D., Moertel C. G., Go V. L., Dimagno E. P. Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer. 1983 Jul 15;52(2):346–352. doi: 10.1002/1097-0142(19830715)52:2<346::aid-cncr2820520228>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  133. Petrek J. A., Sandberg W. A., Bean P. K., Bradley E. L., 3rd Can survival in pancreatic adenocarcinoma be predicted by primary size or stage? Am Surg. 1985 Jan;51(1):42–46. [PubMed] [Google Scholar]
  134. Phelan C. M., Lancaster J. M., Tonin P., Gumbs C., Cochran C., Carter R., Ghadirian P., Perret C., Moslehi R., Dion F. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet. 1996 May;13(1):120–122. doi: 10.1038/ng0596-120. [DOI] [PubMed] [Google Scholar]
  135. Pilepich M. V., Miller H. H. Preoperative irradiation in carcinoma of the pancreas. Cancer. 1980 Nov 1;46(9):1945–1949. doi: 10.1002/1097-0142(19801101)46:9<1945::aid-cncr2820460908>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  136. Pisters P. W., Hudec W. A., Hess K. R., Lee J. E., Vauthey J. N., Lahoti S., Raijman I., Evans D. B. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg. 2001 Jul;234(1):47–55. doi: 10.1097/00000658-200107000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Pitt H. A. Curative treatment for pancreatic neoplasms. Standard resection. Surg Clin North Am. 1995 Oct;75(5):891–904. doi: 10.1016/s0039-6109(16)46734-4. [DOI] [PubMed] [Google Scholar]
  138. Polati E., Finco G., Gottin L., Bassi C., Pederzoli P., Ischia S. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg. 1998 Feb;85(2):199–201. doi: 10.1046/j.1365-2168.1998.00563.x. [DOI] [PubMed] [Google Scholar]
  139. Povoski S. P., Karpeh M. S., Jr, Conlon K. C., Blumgart L. H., Brennan M. F. Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg. 1999 Sep-Oct;3(5):496–505. doi: 10.1016/s1091-255x(99)80103-6. [DOI] [PubMed] [Google Scholar]
  140. Rashleigh-Belcher H. J., Russell R. C., Lees W. R. Cutaneous seeding of pancreatic carcinoma by fine-needle aspiration biopsy. Br J Radiol. 1986 Feb;59(698):182–183. doi: 10.1259/0007-1285-59-698-182. [DOI] [PubMed] [Google Scholar]
  141. Reuther G., Kiefer B., Tuchmann A., Pesendorfer F. X. Imaging findings of pancreaticobiliary duct diseases with single-shot MR cholangiopancreatography. AJR Am J Roentgenol. 1997 Feb;168(2):453–459. doi: 10.2214/ajr.168.2.9016226. [DOI] [PubMed] [Google Scholar]
  142. Robertson D. A., Ayres R., Hacking C. N., Shepherd H., Birch S., Wright R. Experience with a combined percutaneous and endoscopic approach to stent insertion in malignant obstructive jaundice. Lancet. 1987 Dec 19;2(8573):1449–1452. doi: 10.1016/s0140-6736(87)91141-x. [DOI] [PubMed] [Google Scholar]
  143. Roder J. D., Stein H. J., Hüttl W., Siewert J. R. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg. 1992 Feb;79(2):152–155. doi: 10.1002/bjs.1800790219. [DOI] [PubMed] [Google Scholar]
  144. Rodgers P. M., Ward J., Baudouin C. J., Ridgway J. P., Robinson P. J. Dynamic contrast-enhanced MR imaging of the portal venous system: comparison with x-ray angiography. Radiology. 1994 Jun;191(3):741–745. doi: 10.1148/radiology.191.3.8184055. [DOI] [PubMed] [Google Scholar]
  145. Russell R. C. Surgical resection for cancer of the pancreas. Baillieres Clin Gastroenterol. 1990 Dec;4(4):889–916. doi: 10.1016/0950-3528(90)90025-c. [DOI] [PubMed] [Google Scholar]
  146. Rösch T., Lightdale C. J., Botet J. F., Boyce G. A., Sivak M. V., Jr, Yasuda K., Heyder N., Palazzo L., Dancygier H., Schusdziarra V. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992 Jun 25;326(26):1721–1726. doi: 10.1056/NEJM199206253262601. [DOI] [PubMed] [Google Scholar]
  147. Sarfeh I. J., Rypins E. B., Jakowatz J. G., Juler G. L. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy. Am J Surg. 1988 Mar;155(3):411–414. doi: 10.1016/s0002-9610(88)80102-8. [DOI] [PubMed] [Google Scholar]
  148. Sarr M. G., Cameron J. L. Surgical management of unresectable carcinoma of the pancreas. Surgery. 1982 Feb;91(2):123–133. [PubMed] [Google Scholar]
  149. Sasson Aaron R., Hoffman John P., Ross Eric A., Kagan Steven A., Pingpank James F., Eisenberg Burton L. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg. 2002 Mar-Apr;6(2):147–158. doi: 10.1016/s1091-255x(01)00063-4. [DOI] [PubMed] [Google Scholar]
  150. Satake K., Nishiwaki H., Yokomatsu H., Kawazoe Y., Kim K., Haku A., Umeyama K., Miyazaki I. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet. 1992 Sep;175(3):259–265. [PubMed] [Google Scholar]
  151. Sewnath M. E., Birjmohun R. S., Rauws E. A., Huibregtse K., Obertop H., Gouma D. J. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg. 2001 Jun;192(6):726–734. doi: 10.1016/s1072-7515(01)00819-5. [DOI] [PubMed] [Google Scholar]
  152. Sharfman W. H., Walsh T. D. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain. 1990 Jun;41(3):267–271. doi: 10.1016/0304-3959(90)90003-V. [DOI] [PubMed] [Google Scholar]
  153. Sharp K. W., Ross C. B., Halter S. A., Morrison J. G., Richards W. O., Williams L. F., Sawyers J. L. Pancreatoduodenectomy with pyloric preservation for carcinoma of the pancreas: a cautionary note. Surgery. 1989 May;105(5):645–653. [PubMed] [Google Scholar]
  154. Shepherd H. A., Royle G., Ross A. P., Diba A., Arthur M., Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988 Dec;75(12):1166–1168. doi: 10.1002/bjs.1800751207. [DOI] [PubMed] [Google Scholar]
  155. Shinchi Hiroyuki, Takao Sonshin, Noma Hidetoshi, Matsuo Yoichiro, Mataki Yuko, Mori Shinichiro, Aikou Takashi. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):146–150. doi: 10.1016/s0360-3016(01)02806-1. [DOI] [PubMed] [Google Scholar]
  156. Shmulewitz A., Teefey S. A., Robinson B. S. Factors affecting image quality and diagnostic efficacy in abdominal sonography: a prospective study of 140 patients. J Clin Ultrasound. 1993 Nov-Dec;21(9):623–630. doi: 10.1002/jcu.1870210909. [DOI] [PubMed] [Google Scholar]
  157. Silverman D. T., Schiffman M., Everhart J., Goldstein A., Lillemoe K. D., Swanson G. M., Schwartz A. G., Brown L. M., Greenberg R. S., Schoenberg J. B. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999 Aug;80(11):1830–1837. doi: 10.1038/sj.bjc.6690607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Sindelar W. F. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg. 1989 Jan;124(1):127–132. doi: 10.1001/archsurg.1989.01410010137027. [DOI] [PubMed] [Google Scholar]
  159. Smith A. C., Dowsett J. F., Russell R. C., Hatfield A. R., Cotton P. B. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994 Dec 17;344(8938):1655–1660. doi: 10.1016/s0140-6736(94)90455-3. [DOI] [PubMed] [Google Scholar]
  160. Smith C. D., Behrns K. E., van Heerden J. A., Sarr M. G. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg. 1994 Apr;81(4):585–589. doi: 10.1002/bjs.1800810435. [DOI] [PubMed] [Google Scholar]
  161. Smith R. C., Pooley M., George C. R., Faithful G. R. Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function. Surgery. 1985 Jun;97(6):641–648. [PubMed] [Google Scholar]
  162. Snady H., Bruckner H., Cooperman A., Paradiso J., Kiefer L. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer. 2000 Jul 15;89(2):314–327. doi: 10.1002/1097-0142(20000715)89:2<314::aid-cncr16>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  163. Soetikno R. M., Lichtenstein D. R., Vandervoort J., Wong R. C., Roston A. D., Slivka A., Montes H., Carr-Locke D. L. Palliation of malignant gastric outlet obstruction using an endoscopically placed Wallstent. Gastrointest Endosc. 1998 Mar;47(3):267–270. doi: 10.1016/s0016-5107(98)70325-6. [DOI] [PubMed] [Google Scholar]
  164. Sosa J. A., Bowman H. M., Gordon T. A., Bass E. B., Yeo C. J., Lillemoe K. D., Pitt H. A., Tielsch J. M., Cameron J. L. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998 Sep;228(3):429–438. doi: 10.1097/00000658-199809000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Speer A. G., Cotton P. B., Russell R. C., Mason R. R., Hatfield A. R., Leung J. W., MacRae K. D., Houghton J., Lennon C. A. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987 Jul 11;2(8550):57–62. doi: 10.1016/s0140-6736(87)92733-4. [DOI] [PubMed] [Google Scholar]
  166. Spigelman A. D., Talbot I. C., Penna C., Nugent K. P., Phillips R. K., Costello C., DeCosse J. J. Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol. 1994 Aug;47(8):709–710. doi: 10.1136/jcp.47.8.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Spigelman A. D., Williams C. B., Talbot I. C., Domizio P., Phillips R. K. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989 Sep 30;2(8666):783–785. doi: 10.1016/s0140-6736(89)90840-4. [DOI] [PubMed] [Google Scholar]
  168. Splinter T. A., Obertop H., Kok T. C., Jeekel J. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study. J Cancer Res Clin Oncol. 1989;115(2):200–202. doi: 10.1007/BF00397924. [DOI] [PubMed] [Google Scholar]
  169. Steiner E., Stark D. D., Hahn P. F., Saini S., Simeone J. F., Mueller P. R., Wittenberg J., Ferrucci J. T. Imaging of pancreatic neoplasms: comparison of MR and CT. AJR Am J Roentgenol. 1989 Mar;152(3):487–491. doi: 10.2214/ajr.152.3.487. [DOI] [PubMed] [Google Scholar]
  170. Talamini G., Bassi C., Falconi M., Sartori N., Salvia R., Rigo L., Castagnini A., Di Francesco V., Frulloni L., Bovo P. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999 Jul;44(7):1303–1311. doi: 10.1023/a:1026670911955. [DOI] [PubMed] [Google Scholar]
  171. Taylor K. J., Buchin P. J., Viscomi G. N., Rosenfield A. T. Ultrasonographic scanning of the pancreas. Prospective study of clinical results. Radiology. 1981 Jan;138(1):211–213. doi: 10.1148/radiology.138.1.7455085. [DOI] [PubMed] [Google Scholar]
  172. Tersmette A. C., Petersen G. M., Offerhaus G. J., Falatko F. C., Brune K. A., Goggins M., Rozenblum E., Wilentz R. E., Yeo C. J., Cameron J. L. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 2001 Mar;7(3):738–744. [PubMed] [Google Scholar]
  173. Tio T. L., Sie L. H., Tytgat G. N. Endosonography and cytology in diagnosing and staging pancreatic body and tail carcinoma. Preliminary results of endosonographic guided puncture. Dig Dis Sci. 1993 Jan;38(1):59–64. doi: 10.1007/BF01296774. [DOI] [PubMed] [Google Scholar]
  174. Tomiyama T., Ueno N., Tano S., Wada S., Kimura K. Assessment of arterial invasion in pancreatic cancer using color Doppler ultrasonography. Am J Gastroenterol. 1996 Jul;91(7):1410–1416. [PubMed] [Google Scholar]
  175. Trede M., Schwall G., Saeger H. D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990 Apr;211(4):447–458. doi: 10.1097/00000658-199004000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Tsuchiya R., Tsunoda T., Ishida T., Saitoh Y. Resection for cancer of the pancreas--the Japanese experience. Baillieres Clin Gastroenterol. 1990 Dec;4(4):931–939. doi: 10.1016/0950-3528(90)90027-e. [DOI] [PubMed] [Google Scholar]
  177. Vedantham S., Lu D. S., Reber H. A., Kadell B. Small peripancreatic veins: improved assessment in pancreatic cancer patients using thin-section pancreatic phase helical CT. AJR Am J Roentgenol. 1998 Feb;170(2):377–383. doi: 10.2214/ajr.170.2.9456949. [DOI] [PubMed] [Google Scholar]
  178. Vellet A. D., Romano W., Bach D. B., Passi R. B., Taves D. H., Munk P. L. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T. Radiology. 1992 Apr;183(1):87–95. doi: 10.1148/radiology.183.1.1312736. [DOI] [PubMed] [Google Scholar]
  179. Warshaw A. L., Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992 Feb 13;326(7):455–465. doi: 10.1056/NEJM199202133260706. [DOI] [PubMed] [Google Scholar]
  180. Warshaw A. L. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg. 1991 Jan;161(1):26–30. doi: 10.1016/0002-9610(91)90356-i. [DOI] [PubMed] [Google Scholar]
  181. Warshaw A. L., Tepper J. E., Shipley W. U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg. 1986 Jan;151(1):76–80. doi: 10.1016/0002-9610(86)90015-2. [DOI] [PubMed] [Google Scholar]
  182. Watanapa P., Williamson R. C. Resection of the pancreatic head with or without gastrectomy. World J Surg. 1995 May-Jun;19(3):403–409. doi: 10.1007/BF00299172. [DOI] [PubMed] [Google Scholar]
  183. Watanapa P., Williamson R. C. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg. 1992 Jan;79(1):8–20. doi: 10.1002/bjs.1800790105. [DOI] [PubMed] [Google Scholar]
  184. Weese J. L., Nussbaum M. L., Paul A. R., Engstrom P. F., Solin L. J., Kowalyshyn M. J., Hoffman J. P. Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy. Int J Pancreatol. 1990 Aug-Nov;7(1-3):177–185. doi: 10.1007/BF02924235. [DOI] [PubMed] [Google Scholar]
  185. Whelan A. J., Bartsch D., Goodfellow P. J. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med. 1995 Oct 12;333(15):975–977. doi: 10.1056/NEJM199510123331505. [DOI] [PubMed] [Google Scholar]
  186. White R., Lee C., Anscher M., Gottfried M., Wolff R., Keogan M., Pappas T., Hurwitz H., Tyler D. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol. 1999 Jan-Feb;6(1):38–45. doi: 10.1007/s10434-999-0038-z. [DOI] [PubMed] [Google Scholar]
  187. Wigmore S. J., Ross J. A., Falconer J. S., Plester C. E., Tisdale M. J., Carter D. C., Fearon K. C. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996 Jan;12(1 Suppl):S27–S30. doi: 10.1016/0899-9007(96)90014-3. [DOI] [PubMed] [Google Scholar]
  188. Williamson R. C., Bliouras N., Cooper M. J., Davies E. R. Gastric emptying and enterogastric reflux after conservative and conventional pancreatoduodenectomy. Surgery. 1993 Jul;114(1):82–86. [PubMed] [Google Scholar]
  189. Worsey J., Ferson P. F., Keenan R. J., Julian T. B., Landreneau R. J. Thoracoscopic pancreatic denervation for pain control in irresectable pancreatic cancer. Br J Surg. 1993 Aug;80(8):1051–1052. doi: 10.1002/bjs.1800800842. [DOI] [PubMed] [Google Scholar]
  190. Yoshimi F., Hasegawa H., Koizumi S., Amemiya R., Ono H., Kobayashi H., Matsueda K., Itabashi M. Application of three-dimensional spiral computed tomographic angiography to pancreatoduodenectomy for cancer. Br J Surg. 1995 Jan;82(1):116–117. doi: 10.1002/bjs.1800820138. [DOI] [PubMed] [Google Scholar]
  191. Zerbi A., Balzano G., Patuzzo R., Calori G., Braga M., Di Carlo V. Comparison between pylorus-preserving and Whipple pancreatoduodenectomy. Br J Surg. 1995 Jul;82(7):975–979. doi: 10.1002/bjs.1800820738. [DOI] [PubMed] [Google Scholar]
  192. Zerbi A., Fossati V., Parolini D., Carlucci M., Balzano G., Bordogna G., Staudacher C., Di Carlo V. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer. 1994 Jun 15;73(12):2930–2935. doi: 10.1002/1097-0142(19940615)73:12<2930::aid-cncr2820731209>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  193. van Heerden J. A. Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective. World J Surg. 1984 Dec;8(6):880–888. doi: 10.1007/BF01656028. [DOI] [PubMed] [Google Scholar]
  194. van den Bosch R. P., van der Schelling G. P., Klinkenbijl J. H., Mulder P. G., van Blankenstein M., Jeekel J. Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg. 1994 Jan;219(1):18–24. doi: 10.1097/00000658-199401000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES